The authors determined the most useful predictors of common bile duct (CBD) stones as diagnosed by endoscopic retrograde cholangiopancreatography (ERCP) in patients who underwent laparoscopic cholecystectomy (LC).
patients with suspected choledocholithiasis undergoing LC remains uncertain8 and may vary according to local expertise.9 Endoscopic retrograde cholangiopancreatography (ERCP) before LC should not be performed systematically on all patients because ofthe associated morbidity and low yield. 9 Further scrutiny of the usefulness of CBD stone predictors is, therefore, timely. In June 1990, when LC was first introduced in the McGill University teaching institutions, a common approach to patients scheduled to undergo LC was adopted i.e., all patients suspected of having a CBD stone were referred for preoperative ERCP, with attempts at endoscopic sphincterotomy when choledocholithiasis was confirmed.'0 This practice permitted us to study the usefulness of different clinical predictors of CBD stones diagnosed by ERCP in a homogenous patient population. An optimal model ofCBD stone prediction was determined by logistic regression and validated prospectively in a subsequent series of patients undergoing LC.
METHODS

Patient Population
The study population consisted of patients who were scheduled for or underwent LC, in whom ERCP was performed at one of four McGill University teaching hospitals between June 1990 and February 1992. Preoperative ERCP was performed if bile duct stones were suspected. Indications for ERCP included a history ofjaundice or pancreatitis; elevations in serum bilirubin, alkaline phosphatase, gamma glutamyl transferase, aminotransferases, and amylase; and ultrasound findings of a dilated CBD or suspicion of a CBD stone. The criteria used for performing ERCPs after LC were similar to those adopted in the preoperative setting, but also included the intraoperative findings of a dilated cystic duct or CBD stone. In addition to these, postoperative indications for ERCP included the clinical suspicion of a bile leak or bile duct injury. Although not an indication for ERCP, ultrasonographic detection of multiple small gallbladder stones was noted and analyzed as a possible predictor of CBD stones.
Data Collection
All data were obtained from prospective surgical and endoscopic databases. When necessary, data also were collected prospectively and retrospectively from hospital charts, endoscopic reports, abdominal ultrasound, and ERCP films. Age 185 units/L. The highest serum levels within the 10 days before the ERCP examination were recorded for each patient and used for the analysis. Ultrasound studies were performed before ERCP. The common bile duct diameter (in millimeters) was measured in its mid-portion. In addition, a subjective assessment by a blinded examiner was used to determine whether or not there was CBD dilatation considering only the patient's age and the overall appearance of the biliary tree. The suspicion or presence of bile duct stones seen on ultrasound was recorded as was the presence of small, numerous gallbladder stones. The ultrasound reports and films were subsequently reviewed and standardized by an investigator (CP) blinded to the results of the ERCP examinations. Endoscopic retrograde cholangiopancreatography findings, with respect to the presence of bile duct stones and other biliopancreatic pathology, were reported by a certified radiologist. Endoscopic retrograde cholangiopancreatography films and reports were later reviewed independently by a blinded investigator (GG).
Statistical Analysis
The corresponding proportion and total number of patients in whom the information was available were expressed for each clinical predictor. The unit of analysis was a patient, not an ERCP examination. For patients who had more than one ERCP, only the variables noted before the patient's first ERCP and the diagnosis at the definitive ERCP were used for the analysis. When distributed normally, continuous variables were described using mean and standard deviation; if not, they were expressed as median and range. Age was analyzed both as a continuous and a categorical variable using the observed median of the patient population as a cut-off. ideal cut-offs determined at ROC analysis. Common bile duct diameter at ultrasonography was analyzed categorically using the subjective assessment ofenlargement and a cut-off value of >6 mm,'4,'5 with no difference in results. Chi square testing, or Fisher's exact test (where appropriate),'6 were used to determine those clinical variables that were associated with the presence of a CBD stone, when examined individually. Multiple stepwise logistic regression then was used to construct the model that would best predict the presence of a CBD stone at ERCP, considering all clinical predictors together. Goodness of fit ofthe model was assessed using the Pearson's chi square test.'7 Then a probability tree was developed to show the probability of CBD stones according to the presence or absence of the independent predictors identified. Prospective validation of the logistic regression model was performed on a subsequent series of patients scheduled for LC-who first underwent ERCPby comparing their observed CBD stone prevalence with that estimated by the model using chi square testing. '7 In addition, the parameter coefficients of the initial model were compared with those obtained after adding the data of the subsequent series of patients.
RESULTS
Patient Characteristics
The FALSE POSITIVES (1-SPECIFICITY) Figure 1 . Determination of the optimal bilirubin serum cut-off value using ROC curve analysis. The sensitivity and specificity of different bilirubin cutoff values (30, 50, 70, 90 , 100 umol/L) were plotted. The optimal cut-off was 30 Mmol/L (arrow) because it is the point of the curve lying closest to an ideal test with 100% specificity and sensitivity (the upper left most corner of the graph).
Determination of Optimal Serum Cut-Off Values for Biochemical Predictors
Using ROC curve analysis, optimal predictive serum cut-off levels were determined to be 30 ,umol/L for bilirubin (Fig. 1) , 500 units/L for amylase, 120 units/L for AST (similar results were found for ALT, which was available in fewer patients and, therefore, not studied further), and 300 units/L for alkaline phosphatase (Fig.  2) (GGT was not studied further because it was missing in many patients because the biochemical laboratories of participating institutions measure this serum value only if the alkaline phosphatase is elevated). using a cut-offof 55 years), an elevated bilirubin (over 30 gmol/L), the presence ofa dilated CBD on ultrasonography (> 6 mm), and suspected or detected bile duct stone (at ultrasonography). The respective coefficients for each of these were 0.02 (0.88 when dichotomized), 0.83, 0.86, and 1.80. The choice of predictors did not change, whether the post-LC patients were excluded or included in the analysis. The two ultrasonographic predictors exhibited the largest coefficients and thus, were the strongest predictors of choledocholithiasis. Depending on the presence or absence of these four parameters, the model yielded probabilities offinding a bile duct stone at ERCP that ranged from 18% (no predictor present), to 94% (all four predictors present). When a stone was seen on ultrasound, the overall probability of finding a stone at ERCP ranged from 58% to 94%, depending on the presence or absence of the other criteria. Figure 3 shows Some authors examined only preoperative predictors, and others examined a combination of preoperative and intraoperative variables. Furthermore, many ofthe studies were carried out before the availability of modem ultrasonographic equipment.
Accuracy of the Clinical Predictors
All studies were performed before the era of LC-perhaps an important consideration when taking into account the recently reported prevalence of CBD stones that appears to have dropped since the advent of LC.3'32 This decline may be real, possibly reflecting a different patient population that presents earlier in the course of symptomatic gallstone disease, or may be artificial and attributable to decreased detection.3'
Common bile duct stones are found in 3% to 9% of gallstone patients who have never been jaundiced.20 '33-35 No patient with normal liver function tests was found with choledocholithiasis in two series totalling over 400 patients using intraoperative cholangiography (IOC) performed on patients at low risk for carrying CBD stones.3637 Saltztein et al. demonstrated that only the combination of an elevated bilirubin and alkaline phosphatase within the 14 days before open cholecystectomy would significantly predict a CBD stone.38 Many studies have found ultrasonographic criteria to be necessary for the generation ofa good predictive model39-4' because of their stronger predictive abilities when compared with other preoperative clinical criteria.4' Although suggestive ofcholedocholithiasis,42 a dilated CBD alone may be an unreliable indicator,43 perhaps because of the ability of the CBD diameter to change over a short period of time. 44'45 Combining the CBD diameter with other abnormalities, such as an elevated bilirubin, increases its positive predictive value, perhaps by reflecting ongoing biliary obstruction.'5 Conversely, CBD diameter less than 3 mm almost rules out a CBD stone. 46 Lacaine et al. noted that a CBD diameter over 12 mm, with a raised alkaline phosphatase, minimally raised bilirubin, or history ofjaundice gave a 90% to 100% predictive value of CBD stones. 39 In their series, patients with none of these symptoms exhibited a less than 5% risk of choledocholithiasis. They also reported, as others have,'5'4' a significantly older mean age in the patients with choledocholithiasis, but did not otherwise examine this finding. Limitations of this study included the exclusion of all patients with bilirubin levels greater than 3 mg/dL, the absence of multivariate modelling, and the unknown error for each subgroup point estimate. Wilson et al., using IOC, suggested a similar predictive index that included elevated levels ofalkaline phosphatase or bilirubin in the past 6 months, an abnormal CBD, and a dilated cystic duct at surgery. 43 (32-61%22-26) . The model we have generated predicts a CBD stone with a probability ranging from 19% to 38%, in which none or only one criterion is present, to 49% to 94%, in which three or four criteria are fulfilled. A selection based on these predictors should help tailor an appropriate cholangiographic approach, given an individual's risk of CBD stone. The present study design does not permit the identification of an optimal method of cholangiography (ERCP pre-LC or post-LC vs. IOC) because it fails to examine other important considerations, such as the morbidity of the procedure, the implications of a false-positive cholangiographic examination, or a determination of the impact of undetected CBD stones. More precise and unbiased quantifications of these associated factors, which may vary from center to center according to local expertise,9 are required urgently. Until then, based on this report and our previously published experience,10 we would recommend that centers with similar available expertise perform preoperative ERCP in patients exhibiting one or more of the aforementioned strong predictors (other Ann. Surg. -July 1994 than age > 55 years alone). Patients with "weaker" predictors might best be investigated with other methods, such as IOC. 55 The lack of pertinent, comparable data underscores the importance of, and need for long-term prospective trials to better define the optimal roles of different approaches to patients suspected of choledocholithiasis who undergo LC.
